Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Takeda
Information provided by (Responsible Party):
Takeda ( Millennium Pharmaceuticals, Inc. ) Identifier:
First received: August 26, 2011
Last updated: September 14, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)